Polysulfated Glycosaminoglycan

Preferred Label : Polysulfated Glycosaminoglycan;

NCIt synonyms : PSGAG;

NCIt definition : A semi-synthetic glycosaminoglycan (GAG) prepared by extracting GAGs from bovine tracheal cartilage and consisting of mostly chondroitin sulfate, with anti-arthritic activities in animals including dogs. Upon administration, polysulfated GAG (PSGAG), a proteolytic enzyme inhibitor, may inhibit various processes that lead to the loss of cartilaginous mucopolysaccharides. This may include the inhibition of interleukin-1 (IL-1)-mediated inflammation and degradation of cartilage proteoglycans and collagen. PSGAG may also stimulate the synthesis of protein, collagen, proteoglycans, and hyaluronic acid, which may improve joint function.;

UNII : 268AW7000T;

Drug name : Adequan Canine;

NCI Metathesaurus CUI : CL1413018;

Détails

Origin ID

C175559;

UMLS CUI

C0119860;

Currated CISMeF NLP mapping
- glycosaminoglycan polysulfate [MeSH concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- glycosaminoglycan polysulfate [MeSH concept]
Validated automatic mappings to NTBT
- A73025 [MeSH Supplementary Concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients